| A. Pascoal | Tharick | Canada | THE SYNERGY BETWEEN AMYLOID-Β AND A HYPOMETABOLIC DEFAULT MODE NETWORK DETERMINES COGNITIVE DECLINE IN HUMANS AND TRANSGENIC RATS |
| Abisambra | Jose | USA | PERK INHIBITION DEMONSTRATES A NOVEL PATHOLOGICAL MECHANISM IN TAUOPATHIES |
| Abner | Erin | USA | CLINICAL AND NEUROPATHOLOGICAL OUTCOMES AFTER DIAGNOSIS OF MILD COGNITIVE IMPAIRMENT |
| Abraham | Carmela | USA | MODULATING KLOTHO EXPRESSION TOWARDS A NEW TREATMENT FOR ALZHEIMER’S DISEASE |
| Abud | Edsel | USA | HUMAN IPSC-DERIVED MICROGLIA-LIKE CELLS TO STUDY ALZHEIMER’S DISEASE |
| Abushakra | Susan | USA | PERSISTENT EFFICACY OF TRAMIPROSATE IN APOE4 HOMOZYGOUS AD SUBJECTS TREATED OVER 130 WEEKS: RESULTS OF NORTH AMERICAN EXTENSION STUDY |
| Adaikkan | Chinnakkaruppan | USA | LIGHT FLICKER MEDIATED GAMMA FREQUENCY ENTRAINMENT: A NON-INVASIVE APPROACH THAT ENHANCES COGNITIVE ABILITIES AND OFFERS NEUROPROTECTION IN MICE |
| Aigner | Ludwig | Austria | THE ANTI-ASTHMATIC DRUG MONTELUKAST ALTERS MICROGLIA PHENOTYPE AND SYNUCLEOPATHY, AND RESTORES LEARNING AND MEMORY IN AN ANIMAL MODEL OF LEWY BODY DEMENTIA. |
| Ando | Kunie | Belgium | ALZHEIMER RISK FACTOR PICALM LOCALIZATION AND PROTEIN SOLUBILITIES ARE ALTERED IN TAUOPATHIES AND ARE CORRELATED WITH AUTOPHAGY MARKERS |
| Andreasson | Katrin | USA | THE KYNURENINE PATHWAY IN AD: CONTRIBUTION TO PATHOGENESIS THROUGH MODULATION OF IMMUNE CELL RESPONSES AND BIOENERGETICS |
| Anichtchik | Oleg | United Kingdom | BETA-SYNUCLEIN CHANGES IN POST-MORTEM CORTEX OF DEMENTIA WITH LEWY BODIES PATIENTS |
| Ankarcrona | Maria | Sweden | AMYLOID BETA-PEPTIDE AFFECTS THE STRUCTURE AND DYNAMICS OF ER-MITOCHONDRIA CONTACT SITES IN ALZHEIMER’S DISEASE RELATED MODELS |
| Apostolova | Liana | USA | PATIENT AND CAREGIVER VIEWS ON AMYLOID PET IMAGING |
| Arango-Lievano | Margarita | France | DELETION OF NEUROTROPHIN SIGNALING THROUGH THE GLUCOCORTICOID RECEPTOR PATHWAY CAUSES TAU NEUROPATHOLOGY |
| Arbel-Ornath | Michal | USA | STRUCTURAL AND FUNCTIONAL ALTERATIONS OF BRAIN VASCULATURE IN CEREBRAL AMYLOID ANGIOPATHY AND ALZHEIMER’S DISEASE |
| Ashe | Karen | USA | CASPASE-2 CLEAVING TAU REVERSIBLY IMPAIRS MEMORY |
| Ashery | Uri | Israel | MULTIFACETED MITIGATING EFFECTS OF HYPERBARIC OXYGEN THERAPY IN ALZHEIMER’S DISEASE MOUSE MODELS |
| Asnaghi | Veronica | Switzerland | LONG-TERM SAFETY AND TOLERABILITY OF ESCALATING DOSES OF CRENEZUMAB IN PATIENTS WITH MILD-TO-MODERATE ALZHEIMER'S DISEASE |
| Avale | Maria-Elena | Argentina | MODULATION OF 3R:4R TAU ISOFORMS BY RNA REPROGRAMMING: FUNCTIONAL CONSEQUENCES AND THERAPEUTIC PERSPECTIVES |
| Avants | Brian | USA | AMYLOID POSITIVE SUBJECTS EXHIBIT LONGITUDINAL REDUCTIONS IN DEFAULT MODE NETWORK SPONTANEOUS BRAIN ACTIVITY OVER A TWO YEAR PERIOD |
| Ayalon | Gai | USA | PRECLINICAL CHARACTERIZATION, EFFICACY, PHARMACOKINETICS AND PHARMACODYNAMICS AND SAFETY OF RO7105705 – AN ANTI-TAU ANTIBODY CURRENTLY IN CLINICAL DEVELOPMENT FOR ALZHEIMER’S DISEASE |
| Ayton | Scott | Australia | IN VIVO MAPPING OF BRAIN IRON AND ITS RELATIONSHIP WITH AMYLOID BURDEN AND COGNITIVE DECLINE |
| Baglietto-Vargas | David | USA | APPKI-HAΒWT: A NEW ANIMAL MODEL FOR SPORADIC ALZHEIMER’S DISEASE |
| Baranger | Kevin | France | MT5-MMP PROMOTES ALZHEIMER’S PATHOGENESIS IN THE FRONTAL CORTEX OF 5XFAD MICE AND APP TRAFFICKING IN VITRO |
| Bartels | Tim | USA | A UNIVERSAL AGGREGATION MECHANISM FOR FAMILIAL ALPHA-SYNUCLEIN MUTATIONS IN PRION-LIKE SPREAD |
| Bateman | Randall | USA | FROM TRANSLATIONAL RESEARCH TO PREVENTION TRIALS: TARGETING THE PATHOPHYSIOLOGY OF ALZHEIMER’S DISEASE |
| Beher | Dirk | Switzerland | NEXT GENERATION OF HIGHLY BRAIN PENETRANT O-GLCNACASE INHIBITORS AS ORALLY BIOAVAILABLE MODIFIERS OF NEUROFIBRILLARY TANGLE FORMATION FOR THE TREATMENT OF TAUOPATHIES |
| Bennett | Steffany | Canada | TRANSLATIONAL LIPIDOMICS: CAN PATIENTS WITH DLB, ALZHEIMER’S OR MCI BE STRATIFIED BY INTERROGATING THEIR PLASMA LIPIDOMES? |
| Bezprozvanny | Ilya | USA | SYNAPTIC STORE-OPERATED CALCIUM ENTRY PATHWAY AS NOVEL TARGET FOR AD THERAPEUTICS |
| Bingol | Baris | USA | MITOPHAGY PATHWAYS IN PARKINSON'S DISEASE |
| Blanc | Frederic | France | LONG TERM COGNITIVE OUTCOME OF DEMENTIA WITH LEWY BODIES AND ALZHEIMER’S DISEASE: DUAL PATHOLOGY IS WORSE |
| Blauwendraat | Cornelis | USA | SCREENING OF PATHOGENIC AND RISK VARIANTS IN NEURODEGENERATIVE DISEASES USING THE NEW NEUROCHIP ARRAY |
| Blennow | Kaj | Sweden | FLUID BIOMARKERS IN ALZHEIMER’S DISEASE TRIALS: TOOLS FOR DIAGNOSTIC ENRICHMENT AND TO IDENTIFY DRUG EFFECTS ON PATHOPHYSIOLOGY |
| Blesa Gonzalez | Rafael | Spain | THE IMPACT OF OBESITY AND WEIGHT LOSS ON BRAIN STRUCTURE: A 2-YEARS PROSPECTIVE STUDY |
| Bolotina | Victoria | USA | IMPAIRMENT OF PARK14-DEPENDENT CA2+ SIGNALING AS A NOVEL DETERMINANT OF HUMAN PARKINSON'S DISEASE |
| Bonvento | Gilles | France | METABOLIC DEPLETION OF L-SERINE IN ASTROCYTES IMPAIRS SYNAPTIC PLASTICITY IN A MOUSE MODEL OF ALZHEIMER'S DISEASE |
| Bouvier | David | Luxembourg | IMPACT OF MICROGLIA ON THE HIPPOCAMPUS DETERIORATION IN ALZHEIMER’S DISEASE |
| Bradshaw | Elizabeth | USA | SHARED POLYGENIC CONTRIBUTIONS TO NEURODEGENERATIVE AND IMMUNE-RELATED TRAITS REVEALS EFFECTS OF SUSCEPTIBILITY LOCI ON MICROGLIAL ACTIVATION |
| Brion | Jean-Pierre | Belgium | PHF FROM ALZHEIMER BRAIN INDUCE SEEDING OF AN ARGYROPHILIC 4R TAU PATHOLOGY IN WILD-TYPE MICE |
| Brudek | Tomasz | Denmark | SHIFT IN ANTI-ALPHA-SYNUCLEIN AUTOANTIBODY PATTERNS IN PARKINSON’S DISEASE AND MULTIPLE SYSTEM ATROPHY |
| Brys | Miroslaw | USA | RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE ASCENDING DOSE STUDY OF ANTI-ALPHA-SYNUCLEIN ANTIBODY BIIB054 IN HEALTHY VOLUNTEERS |
| Bu | Buojun | USA | CENTRAL AND PERIPHERAL APOE IN COGNITION AND AD |
| Buée | Luc | France | TAU STRAINS AND MECHANISMS OF PRION-LIKE PROPAGATION |
| Burnham | Samantha | Australia | ESTIMATING THE AGE OF ONSET FOR BIO-MARKERS OF AD |
| Butovsky | Oleg | USA | THE TREM2-APOE PATHWAY INDUCES DYSFUNCTIONAL MICROGLIA IN NEURODEGENERATION |
| Buttini | Manuel | Luxembourg | AGGREGATION-INDEPENDENT NEURODEGENERATION AND MICROGLIOSIS IN A MOUSE MODEL OF PRION-LIKE ALPHA-SYNUCLEIN SPREADING. |
| Cacace | Rita | Belgium | IDENTIFICATION OF DIPEPTIDYL PEPTIDASE 6 AS A NOVEL CANDIDATE IN NEURODEGENERATIVE BRAIN DISEASES |
| Calatayud Aristoy | Carles | Spain | DISSECTING PARKINSON’S DISEASE GENETIC COMPLEXITY BY COMBINING GENE EDITING AND PATIENT’S CELLS |
| Capotosti | Francesca | Switzerland | NOVEL PET TRACERS OF ALPHA-SYNUCLEIN FOR THE DIAGNOSIS OF PARKINSON'S DISEASE |
| Capotosti | Francesca | Switzerland | SMALL MOLECULES TARGETING TAU PROPAGATION DEMONSTRATE EFFICACY IN AN AGGRESSIVE TAUOPATHY MOUSE MODEL |
| Casadei | Nicolas | Germany | MODULATION OF THE GASTROINTESTINAL MICROBIOME INDUCED BY ALPHA-SYNUCLEIN OVEREXPRESSION IN PARKINSON´S DISEASE RODENT TRANSGENIC MODELS |
| Cavallini | Annalisa | United Kingdom | CHARACTERISATION OF EXTRACELLULAR TAU IN CONDITIONED MEDIA FROM CELL MODELS OF TAU AGGREGATION |
| Ceccaldi | Mathieu | France | IMPACT OF FLORBETABEN PET IMAGING ON DIAGNOSIS AND MANAGEMENT OF PATIENTS WITH SUSPECTED AD ELIGIBLE FOR CSF ANALYSIS IN FRANCE |
| Checler | Frédéric | France | AUTOPHAGY IN ALZHEIMER: WHAT BESIDES ABETA? |
| Chen | Yun-Ru (Ruby) | Taiwan R.O.C. | UNDERSTANDING TDP-43 OLIGOMERS AND DIPEPTIDE REPEATS IN FRONTOTEMPORAL DEMENTIA AND AMYOTROPHIC LATERAL SCLEROSIS |
| Chen | Liam | USA | IMPAIRED TDP-43 REPRESSION OF NONCONSERVED CRYPTIC EXONS IN ALZHEIMER’S DISEASE |
| Chéraud | Chrystel | France | AMYLOID PET IN DEMENTIA WITH LEWY BODIES IN THE EARLY STAGE |
| Chiba-Falek | Ornit | USA | REGULATION OF GENE EXPRESSION: THE GENETIC MECHANISMS UNDERLYING NEURODEGENERATIVE DISEASES |
| Cioffi | Federica | The Netherlands | THE EFFECT OF SIMULTANEOUS ADMINISTRATION OF TWO PROTEOLYTIC ENZYMES ON THE CLEARANCE OF AMYLOID-BETA PEPTIDE |
| Claeysen | Sylvie | France | IMPACT OF GUT MICROBIOTA IN A MOUSE MODEL OF ALZHEIMER'S DISEASE |
| Cleveland | Don | USA | GENE SILENCING THERAPY FOR HUMAN NEURODEGENERATIVE DISEASE |
| Colom-Cadena | Martí | Spain | IMAGING SYNAPTIC PATHOLOGY IN DEMENTIA WITH LEWY BODIES |
| Connolly | Niamh | Ireland | THE CELLULAR BIOENERGETICS IN NEURODEGENERATIVE DISEASES CONSORTIUM COMBINES SYSTEMS MODELLING WITH IN VITRO ANALYSIS TO INVESTIGATE NEURODEGENERATIVE MITOCHONDRIAL RESPIRATORY DYSFUNCTION IN AD, PD AND HD |
| Corriveau | Roderick | USA | VASCULAR CONTRIBUTIONS TO COGNITIVE IMPAIRMENT AND DEMENTIA (VCID) BIOMARKERS CONSORTIUM |
| Cresto | Noemie | France | THE LRRK2 G2019S MUTATION BUT NOT ITS DEAD KINASE FORM INCREASES THE NEUROTOXICITY OF MUTANT A53T A-SYNUCLEIN |
| Croft | Cara | USA | BRAIN SLICE CULTURE MODELS OF TAUOPATHIES AND OTHER CNS PROTEINOPATHIES |
| Cuello | Claudio A. | Canada | AN EVOLVING METABOLIC NGF DEREGULATION IN THE ALZHEIMER’S AND DOWN SYNDROME PATHOLOGIES |
| Dalrymple-Alford | John | New Zealand | PARKINSON’S DISEASE: OPTIMISING NEUROPSYCHOLOGICAL TESTING TO IDENTIFY RISK OF PROGRESSION TO DEMENTIA. |
| Dawson | Ted | USA | LYMPHOCYTE ACTIVATION GENE 3 IS THE NEURON TRANSMISSION RECEPTOR FOR PRIONIC SPREAD OF PATHOLOGIC ALPHA-SYNUCLEIN |
| De Jager | Philip | USA | TAU BUT NOT AMYLOID PATHOLOGY IS ASSOCIATED WITH LARGE-SCALE EPIGENOMIC CHANGES IN THE HUMAN BRAIN |
| De Roeck | Arne | Belgium | DELETERIOUS ABCA7 MUTATIONS AND TRANSCRIPT RESCUE MECHANISMS IN EARLY-ONSET ALZHEIMER’S DISEASE |
| De Strooper | Bart | Belgium | THE CELLULAR PHASE OF ALZHEIMER DISEASE |
| De Vos | Ann | Belgium | PROTEIN TAU PREDICTS STROKE SEVERITY AND OUTCOME IN ACUTE ISCHEMIC STROKE |
| Dekens | Doortje | The Netherlands | ESSENTIAL PROTECTIVE FUNCTION OF TUMOR NECROSIS FACTOR RECEPTOR 2 SIGNALLING IN ACUTE MODELS OF ALZHEIMER’S DISEASE |
| Del Campo Milan | Marta | The Netherlands | BRI2 DEMENTIA PATHWAY IN CSF, IMPROVING DETECTION THROUGH ULTRASENSITIVE SIMOA TECHNOLOGY |
| DeVos | Sarah | USA | IN VIVO MONITORING AND ANALYSIS OF TAU AGGREGATION AND SPREADING |
| Dewachter | Ilse | Belgium | TAU-INTERACTOME MAPPING BASED IDENTIFICATION OF TAU MODIFIERS AND THEIR IN VITRO AND IN VIVO VALIDATION IN TAU TRANSGENIC MICE. |
| Dhenain | Marc | France | REORGANIZATION OF AMYLOID DISTRIBUTION PATTERNS FOLLOWING ALZHEIMER BRAIN HOMOGENATE INOCULATION IN TRANSGENIC MICE |
| Diamond | Marc | USA | TAU PRION STRAINS AS THE BUILDING BLOCKS OF SYNDROMIC DIVERSITY IN TAUOPATHIES |
| Dickstein | Dara | USA | [18F]T807/AV-1451 (FLORTAUCIPIR) IMAGING IN ATHLETES WITH POSTCONCUSSIVE SYNDROMES INCLUDING CLINICALLY PROBABLE CTE: PROMINENCE OF PSYCHIATRIC CLINICAL SYMPTOMS AND IMPLICATIONS FOR EXPERIMENTAL THERAPY |
| Do Carmo | Sonia | Canada | DNA DEMETHYLATION AS A THERAPEUTIC TARGET IN ALZHEIMER’S DISEASE |
| Dorostkar | Mario | Germany | QUANTIFICATION OF INHIBITORY AND EXCITATORY SYNAPSE LOSS IN ALZHEIMER'S DISEASE |
| Duff | Karen | USA | PROPAGATION OF TAU AS A THERAPEUTIC TARGET |
| Dunah | Anthone | USA | PICK1 IS A NOVEL SYNAPTO-PROTECTIVE TARGET FOR ALZHEIMER’S DISEASE |
| Duplan | Eric | France | P53 UPREGULATES Α-SYNUCLEIN: A MECHANISM THAT COULD CONTRIBUTE TO ACCUMULATION OF TOXIC AGGREGATED SYNUCLEIN IN PARKINSON’S DISEASE (PD) |
| Dutta | Aloke | USA | A NOVEL IRON (II) PREFERRING DOPAMINE AGONIST CHELATOR D-607 SIGNIFICANTLY SUPPRESSES Α-SYN- AND MPTP-INDUCED TOXICITIES IN VIVO |
| Dutta Passecker | Priyanka | United Kingdom | FRONTOTEMPORAL DEMENTIA AND PARKINSON’S DISEASE CELLULAR MODELS: IN-VITRO CHARACTERIZATION OF PATHOLOGICAL PHENOTPYES IN GENE-EDITED IPSC-DERIVED NEURONS WITH MAPT AND LRRK2 MUTATIONS |
| Eimer | William | USA | ALZHEIMER’S DISEASE ASSOCIATED PATHOLOGIES INDUCED BY PATHOGEN-MEDIATE BETA-AMYLOID DEPOSITION |
| Eisele | Yvonne | USA | IDENTIFICATION AND CHARACTERIZATION OF NOVEL, HIGHLY STABLE, CYTOTOXIC TRANSTHYRETIN (TTR) OLIGOMERS IN TTR-RELATED AMYLOID DISORDERS |
| El-Agnaf | Omar | Qatar | EXPLORING THE POTENTIAL ROLE OF ALPHA-SYNUCLEIN SPECIES AS PARKINSON’S DISEASE BIOMARKERS IN LRRK2 MUTATION CARRIERS COHORT. |
| Eldar-Finkelman | Hagit | Israel | NEW MODALITY OF GSK-3 INHIBITION HOLDS PROMISE IN TREATING NEURODEGENERATIVE DISORDERS |
| Elmsaouri | Sara | USA | IDENTIFYING MODULATORS OF GENOMIC STABILITY IN ALZHEIMER’S DISEASE |
| Endres | Kristina | Germany | ALTERED GUT MICROBIOME COMPOSITION AND DIGESTIVE ENZYME ACTIVITY OF THE 5XFAD ALZHEIMER MOUSE MODEL |
| Erskine | Daniel | United Kingdom | SUBCORTICAL VISUAL SYSTEM PATHOLOGY AND HALLUCINATIONS IN DEMENTIA WITH LEWY BODIES |
| Eskildsen | Simon | Denmark | CORTICAL CAPILLARY DYSFUNCTION IS ASSOCIATED WITH WHITE MATTER HYPERINTENSITIES IN ALZHEIMER’S DISEASE |
| Esposito | Giuseppe | Italy | AUTOLOGOUS TRANSPLANTATION OF ENTERIC GLIA IMPROVES NEUROPATHOLOGY AND RESTORES COGNITIVE DEFICITS IN Β AMYLOID-INDUCED NEURODEGENERATION. |
| Fahnestock | Margaret | Canada | TAU MODULATES BDNF EXPRESSION AND MEDIATES AΒ-INDUCED BDNF DOWN-REGULATION IN ANIMAL AND CELLULAR MODELS OF ALZHEIMER’S DISEASE |
| Falahati | Farshad | Sweden | ASSOCIATIONS OF LONGITUDINAL BRAIN STRUCTURAL CHANGES WITH COGNITION, APOE GENOTYPE AND AMYLOID BURDEN IN MILD COGNITIVE IMPAIRMENT |
| Farrer | Lindsay | USA | NOVEL GENETIC VARIANTS AND LOCI INFLUENCING RISK OF ALZHEIMER’S DISEASE IDENTIFIED BY WHOLE EXOME SEQUENCING USING AN ENRICHED CASE-CONTROL DESIGN |
| Ferreira | Daniel | Sweden | SUBJECTIVE MEMORY DECLINE: ATROPHY PATTERNS, COGNITION, AMYLOID BURDEN AND CLINICAL PROGRESSION OVER 7.5 YEARS |
| Ferretti | Maria Teresa | Switzerland | ALZHEIMER PATHOLOGY, T CELL EXTRAVASATION AND CHOROID PLEXUS ACTIVATION - A PILOT STUDY IN HUMAN POST-MORTEM SAMPLES |
| Ffytche | Dominic | United Kingdom | BIOMARKERS OF EARLY-ONSET PSYCHOSIS IN PARKINSON’S DISEASE |
| Fortea | Juan | Spain | MICROSTRUCTURAL CORTICAL CHANGES ALONG THE ALZHEIMER'S DISEASE CONTINUUM |
| Frenkel | Dan | Israel | THE LINK BETWEEN PRESENILIN TO MICROGLIA ACTIVITY IN ALZHEIMER'S DISEASE |
| Friedland | Robert | USA | THE INFLUENCE OF BACTERIAL AMYLOID ON ALPHA SYNUCLEIN (AS) AGGREGATION AND NEUROINFLAMMATION IN THE RAT AND CAENORHABDITIS ELEGANS |
| Frisoni | Giovani B | Italy | BIOMARKER MATRIX SENSITIVE TO THE PROGRESSION OF ALZHEIMER’S DISEASE |
| Funamoto | Satoru | Japan | POTENTIAL DETERMINATION MECHANISM OF EPSILON-CLEAVAGE SITES: IMPLICATION FOR DETERMINANTS OF ABETA40 AND ABETA42 PRODUCTION LINES |
| Futerman | Tony | Israel | UNRAVELING THE MECHANISTIC CONNECTION BETWEEN GBA1 MUTATIONS AND PARKINSON’S DISEASE |
| Ganz | Andrea | The Netherlands | NEUROPATHOLOGICAL ASSESSMENT OF COGNITIVELY HEALTHY CENTENARIANS – THE 100-PLUS STUDY |
| Garcia Reitboeck | Pablo | United Kingdom | INDUCED PLURIPOTENT STEM CELL-DERIVED MACROPHAGES AS A MODEL TO STUDY THE ROLE OF TREM2 IN ALZHEIMER’S DISEASE |
| Garn | Heinrich | Austria | APPLICATION OF THE QUANTITATIVE ELECTROENCEPHALOGRAM IN DEMENTIA DIAGNOSIS |
| Geula | Changiz | USA | AGE-RELATED INTRANEURONAL CALCIUM DYSREGULATION AND NEURONAL VULNERABILITY IN ALZHEIMER’S DISEASE |
| Ghiso | Jorge | USA | AMYLOID BETA CATABOLISM: A BALANCING ACT BETWEEN EFFECTIVE BRAIN CLEARANCE AND THE PROCESS OF AMYLOIDOGENESIS |
| Giladi | Nir | Israel | PERSONALIZED APPROACH TO PD TREATMENT, THE ROLE OF MUTATIONS IN THE GBA AND LRRK2 GENES |
| Gold | Gabriel | Switzerland | SORTING OUT THE COGNITIVE IMPACT OF CEREBRAL MICROINFARCTS AND MICROBLEEDS |
| Golde | Todd | USA | TARGETING IMMUNOPROTEOSTASIS IN AD AND PD |
| Goldhardt | Oliver | Germany | KALLIKREIN-RELATED PEPTIDASES IN ALZHEIMER’S DISEASE – SUITABLE BIOMARKERS FOR AMYLOID PATHOLOGY? |
| Gomperts | Stephen | USA | PET IMAGING OF TAU AGGREGATES IN THE LEWY BODY DISEASES |
| Graham | Leah | USA | DIET-INDUCED NEUROINFLAMMATION AND VASCULAR DYSFUNCTION CAUSE WHITE MATTER DAMAGE IN THE AGING BRAIN |
| Grasset | Leslie | France | TIME TRENDS IN LEVEL AND DECLINE OF COGNITION AND FUNCTION OF ELDERLY PEOPLE 10 YEARS APART: THE PAQUID STUDY |
| Grimmer | Timo | Germany | ALTERED NEURO-VASCULAR COUPLING IN ALZHEIMER DISEASE AS MEASURED BY OPTICAL IMAGING: A PROMISING BIOMARKER |
| Growdon | John H. | USA | NEUROIMAGING BIOMARKERS IN LEWY BODY DISEASES: NEUROPATHOLOGIC CONFIRMATION |
| Gupta | Veer Bala | Australia | ESTABLISHING A LINK BETWEEN PROTEIN METABOLISM AND ALZHEIMER’S DISEASE: BASED ON THE LONGITUDINAL PROTEOMICS DATA FROM AN AGING COHORT |
| Haass | Christian | Germany | TREM2 - FROM CELLULAR MECHANISMS TO HUMAN PATIENTS |
| Haines | Jonathan | USA | IN SILICO FUNCTIONAL ANNOTATION OF GENOMIC VARIANTS AND MULTI-GENE ANALYSES IN LATE ONSET ALZHEIMER’S DISEASE |
| Hajos-Korcsok | Eva | USA | PRECLINICAL PHARMACOLOGY AND TOXICOLOGY OF PF-06648671, A NOVEL GAMMA SECRETASE MODULATOR: COMPARISON TO GAMMA SECRETASE INHIBITORS |
| Hall | Helene | Canada | TARGETING M1 MUSCARINIC AND SIGMA-1 RECEPTORS IN ALZHEIMER'S DISEASE: REVERSAL OF PATHOLOGICAL HALLMARKS AND ASSOCIATED COGNITIVE DYSFUNCTION IN MCGILL-R-THY1-APP RATS |
| Hall | Sara | Sweden | BLOOD-BASED NFL: A BIOMARKER FOR DIFFERENTIAL DIAGNOSIS OF PARKINSONIAN DISORDERS |
| Hamm | Matthew | USA | PHOSPHORYLATION AT A LRRK2-TARGETED TAU EPITOPE REVEALS NOVEL PATHOLOGICAL STAINING IN TAUOPATHIES |
| Hanger | Diane | United Kingdom | A HUMAN TAUOPATHY-ASSOCIATED TAU FRAGMENT INDUCES MOTOR AND COGNITIVE DEFICITS AND TAU AGGREGATION IN MICE |
| Hansson | Oskar | Sweden | CONCORDANCE BETWEEN NEW ELECSYS(R) CSF ASSAYS (ABETA(1-42), TOTAL TAU AND PHOSPHORYLATED TAU) AND AMYLOID PET IMAGING IN BIOFINDER AND ADNI |
| Hardy | John | United Kingdom | GENETICS OF THE LYSOSOME AND PARKINSON’S DISEASE |
| Harrison | Ian | United Kingdom | GLYMPHATIC CLEARANCE IMPAIRED IN A MOUSE MODEL OF TAUOPATHY: CAPTURED USING CONTRAST-ENHANCED MRI |
| Hartmann | Tobias | Germany | BIOMARKER RESULTS OF THE LIPIDIDIET TRIAL ON FORTASYN CONNECT INTERVENTION IN PRODROMAL ALZHEIMER’S DISEASE |
| Harvey | Kirsten | United Kingdom | WNT AND CA2+ SIGNALLING CHANGES IN LRRK2 PARKINSON’S DISEASE MODELS |
| Hecimovic | Silva | Croatia | BACE1-CLEAVAGE OF SEZ6 AND SEZ6L PROTEINS IS ENHANCED IN NIEMANN-PICK TYPE C DISEASE MODELS |
| Helwig | Michael | Germany | WHOLE BRAIN IMAGING AND 3D-MODELING OF ALPHA-SYNUCLEIN TRANSMISSION IN OPTICALLY CLEARED MOUSE TISSUE |
| Henjum | Kristi | Norway | CEREBROSPINAL FLUID SOLUBLE TREM2 IN AGING AND ALZHEIMER’S DISEASE |
| Herms | Jochen | Germany | BACE1 INHIBITION IN AD THERAPY AND ITS POTENTIAL SYNAPTIC SIDE EFFECTS - A WALK ON A TIGHTROPE? |
| Hock | Christoph | Switzerland | ANTIBODY THERAPY FOR ALZHEIMER’S DISEASE - KEY CHALLENGES |
| Holstege | Henne | The Netherlands | PROTEIN TRUNCATING AND RARE DAMAGING VARIANTS IN THE SORL1 GENE CAUSE ALZHEIMER’S DISEASE |
| Holtzman | David | USA | EFFECTS OF APOE ON TAU AND NEURODEGENERATION |
| Hondius | David | The Netherlands | PROTEOMICS ANALYSIS OF CAPILLARY CEREBRAL AMYLOID ANGIOPATHY |
| Hoozemans | Jeroen | The Netherlands | UNFOLDED PROTEIN RESPONSE ACTIVATION IN C9ORF72 FRONTOTEMPORAL DEMENTIA CASES |
| Hort | Jakub | Czech Republic | CLINICAL AND RESEARCH UTILITY OF SPATIAL NAVIGATION ASSESSMENT IN ALZHEIMER´S DISEASE |
| Horvath | Istvan | Sweden | CROSS-TALK BETWEEN AMYLOIDOGENIC PROTEINS IN TYPE-2 DIABETES AND PARKINSON’S DISEASE |
| Houben | Sarah | Belgium | EXPRESSION OF FTDP-17 MUTANT TAU IN TRANSGENIC MICE DECREASES ADULT NEUROGENESIS IN THE DENTATE GYRUS |
| Hudry | Eloise | USA | APOLIPOPROTEIN E: A COMPLEX MODULATOR OF NEURONAL NETWORK INTEGRITY IN PHYSIOLOGICAL AND PATHOLOGICAL CONTEXTS |
| Hugon | Jacques | France | THERAPEUTIC STRATEGIES WITH PKR AND JNK INHIBITIONS: PRECLINICAL AND CLINICAL FINDINGS |
| Hultqvist | Greta | Sweden | BIVALENT BRAIN SHUTTLE INCREASES ANTIBODY UPTAKE BY MONOVALENT BINDING TO THE TRANSFERRIN RECEPTOR |
| Hyman | Bradley | USA | MOLECULAR UNDERPINNINGS OF PROGRESSION IN ALZHEIMER’S DISEASE |
| Inestrosa | Nibaldo C. | Chile | NEUROPROTECTION OF AD IN OCTODON DEGUS: ROLE OF WNT PATHWAY |
| Iqbal | Khalid | USA | PASSIVE IMMUNIZATION TARGETING AMINO-TERMINAL OF TAU INHIBITS NOT ONLY TAU BUT ALSO ABETA PATHOLOGY |
| Isacson | Ole | USA | THE CONVERGENCE OF LYSOSOMES AND LIPIDS IN NEURODEGENERATION |
| Ishii | Makoto | USA | BODY WEIGHT DEFICITS AND ALTERATIONS IN PLASMA ADIPOKINE LEVELS IN THE PRECLINICAL STAGE OF ALZHEIMER’S DISEASE |
| Ittner | Lars | Australia | ON THE MOLECULAR ROLE OF TAU IN REGULATING POST-SYNAPTIC TOXICITY |
| Iwatsubo | Takeshi | Japan | JAPANESE ADNI: OVERVIEW OF THE CLINICAL AND IMAGING DATA |
| Jackson | Johanna | United Kingdom | IN VIVO TWO-PHOTON IMAGING OF THE EFFECTS OF TAUOPATHY AND AMYLOIDOPATHY ON SYNAPSES |
| Jäkel | Lieke | The Netherlands | PATHOBIOLOGICAL CHARACTERISTICS OF AMYLOID-BETA43 AND AMYLOID-BETA(PE3)42: MISSING PEPTIDES IN CAA |
| Jang | Ming-Kuei | Taiwan R.O.C. | NOVEL IMAGING TRACERS, 18F-PM-PBB3 AND 18F-AM-PBB3, FOR VISUALIZATION AND QUANTIFICATION OF FIBRILLARY TAU PATHOLOGIES WITH POSITRON EMISSIONN TOMOGRAPHY |
| Jankovic | Joseph | USA | RESULTS FROM A PHASE 1B MULTIPLE ASCENDING-DOSE STUDY OF PRX002, AN ANTI-ALPHA-SYNUCLEIN MONOCLONAL ANTIBODY, IN PATIENTS WITH PARKINSON’S DISEASE |
| Jankowsky | Joanna | USA | A NEW CHEMOGENETIC SYSTEM FOR MODELING CIRCUIT DYSFUNCTION IN NEURODEGENERATIVE DISEASE |
| Jensen | Poul Henning | Denmark | REDUCED CYTOSOLIC CALCIUM CAUSED BY SERCA ACTIVATION IS AN EARLY AND PATHOGENIC EVENT IN THE NEURODEGENERATION CAUSED BY ALPHA-SYNUCLEIN OLIGOMERS |
| Jeon | Beomseok | Korea | RBD [REM SLEEP BEHAVIOR DISORDER] AND PARKINSON'S DISEASE PROGNOSIS |
| Johnson | Keith | USA | STAGING AD PATHOLOGY WITH PET |
| Jørgensen | Arne Lund | Denmark | DEVELOPMENT OF A LARGE ANIMAL MODEL OF ALZHEIMER’S DISEASE IN GOTTINGEN MINIPIGS |
| Karampetsou | Mantia | Greece | PHOSPHORYLATED ALPHA-SYNUCLEIN FIBRILS PROMOTE PATHOLOGY AND NEURODEGENERATION IN VIVO |
| Keator | David | USA | BASELINE [18F]AV-45 PET PREDICTORS OF DEMENTIA TRANSITION IN DOWN SYNDROME |
| Kiely | Aoife | United Kingdom | ALPHA-SYNUCLEIN DEGRADATION IN MULTIPLE SYSTEM ATROPHY |
| Kim | Jungsu | USA | MICRORNA-874 DOWNREGULATES BACE1 EXPRESSION AND DRAMATICALLY INHIBITS AMYLOID ACCUMULATION IN THE BRAIN |
| Kins | Stefan | Germany | APLP1 IS A SYNAPTIC CELL ADHESION MOLECULE, SUPPORTING MAINTENANCE OF DENDRITIC SPINES AND BASAL SYNAPTIC TRANSMISSION |
| Kitazume | Shinobu | Japan | ENDOTHELIAL O-GALNAC GLYCOSYLATION PATHWAY DETERMINES APP PROCESSING FOR VASCULAR AΒ DEPOSITION |
| Klenerman | David | United Kingdom | DETECTING AND CHARACTERISING INDIVIDUAL OLIGOMERS PRESENT IN HUMAN CSF |
| Kofler | Julia | USA | THE PSYCHOSIS PHENOTYPE OF ALZHEIMER’S DISEASE IS ASSOCIATED WITH INCREASED TAU BURDEN AND SHIFT IN MICROGLIAL ACTIVATION |
| Koo | Edward | USA | SYNAPTIC INJURY IN ALZHEIMER DISEASE: INSIGHTS FROM TARGETED EXPRESSION OF APP AND TAU IN MICE |
| Koprich | James | Canada | REPRODUCIBILITY OF A MACAQUE MODEL OF PARKINSON'S DISEASE ALPHA-SYNUCLEINOPATHY |
| Korczyn | Amos | Israel | IS PARKINSON REALLY A PRION DISEASE? |
| Korhonen | Ville | Finland | C9ORF72 EXPANSION ASSOCIATED IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS: A POTENTIAL COMORBIDITY WITH BEHAVIOURAL VARIANT FRONTOTEMPORAL DEMENTIA |
| Kouroupi | Georgia | Greece | DEFECTIVE SYNAPTIC CONNECTIVITY AND AXONAL NEUROPATHOLOGY IN A HUMAN IPSC-BASED MODEL OF FAMILIAL PARKINSON'S DISEASE |
| Kovacs | Gabor G. | Austria | EVALUATING THE PATTERNS OF AGING-RELATED TAU ASTROGLIOPATHY (ARTAG) UNRAVELS NOVEL INSIGHTS INTO BRAIN-AGEING AND NEURODEGENERATIVE DISEASES |
| Koval | Erica | USA | TREM2 GENETIC DELETION EXACERBATES THE DISEASE COURSE IN THE SOD1G93A MOUSE MODEL OF ALS |
| Kratzer | Ingrid | Austria | NSC-COMPOUNDS, A NOVEL THIOPHENE SCAFFOLD, REDUCE AMYLOID AND P-TAU, AND IMPROVE SPATIAL MEMORY IN A MOUSE MODEL OF ALZHEIMER’S DISEASE |
| Krumpolec | Patrik | Slovak Republic | BENEFITS OF ENDURANCE-STRENGTH TRAINING IN PATIENTS WITH PARKINSON'S DISEASE |
| Kulisevsky | Jaime | Spain | HALLUCINATIONS IN PARKINSONS DISEASE |
| Lammich | Sven | Germany | BACE1 TRANSLATION IS FACILITATED BY AN IRE1 MEDIATED ENDONUCLEOLYTIC CLEAVAGE OF ITS INHIBITORY 5'UTR |
| Lanzillotta | Chiara | Italy | THE UNFOLDED PROTEIN RESPONSE IS A MAJOR PARTICIPANT IN THE DEVELOPMENT OF ALZHEIMER DISEASE SYMPTOMATOLOGY IN A MOUSE MODEL OF DOWN SYNDROME |
| Lautenschläger | Janin | United Kingdom | ALPHA-SYNUCLEIN - SUPER-RESOLUTION MICROSCOPY REVEALS POTENTIAL NEW ROLE AT THE PRE-SYNAPSE |
| LaVoie | Matt | USA | CELL AUTONOMOUS AND NON-AUTONOMOUS G2019S LRRK2 DYSFUNCTION |
| Lazarov | Orly | USA | MECHANISMS OF COGNITIVE DEFICITS AND BLOOD BIOMARKERS IN ALZHEIMER’S DISEASE |
| Leal | Nuno Santos | Sweden | MODULATION OF ER-MITOCHONDRIA CONTACTS SITES INFLUENCE AUTOPHAGOSOME PRODUCTION |
| LeBlanc | Andrea | Canada | CASPASE-6, AS A NOVEL THERAPEUTIC TARGET OF AGE-DEPENDENT COGNITIVE IMPAIRMENT AND ALZHEIMER DISEASE. |
| Lee | Virginia M.Y. | USA | TRANSMISSION OF Α-SYNUCLEIN STRAINS IN SYNUCLEINOPATHIES |
| Lee | Dong Young | Republic of Korea | KOREAN BRAIN AGING STUDY FOR EARLY DIAGNOSIS AND PREDICTION OF ALZHEIMER’S DISEASE (KBASE) |
| Lee | Seung-Jae | Republic of Korea | ROLE OF LYSOSOME IN PROTEIN AGGREGATE PROPAGATION |
| Lee | Edward | USA | LOSS OF TDP-43 CONTRIBUTES TO NON-CODING RNA MEDIATED TOXICITY |
| Lehtonen | Sarka | Finland | INVESTIGATING PARKINSONʼS DISEASE USING HUMAN STEM CELL-DERIVED ASTROCYTES |
| Lemere | Cynthia | USA | MURINE ANTI-PYROGLUTAMATE-3 ABETA MAB, 07/2A, SPARES COGNITION, REDUCES PLAQUES AND IN COMBINATION WITH GLUTAMINYL CYCLASE INHIBITOR PQ912 FURTHER IMPROVES EFFICACY |
| Leroy | Karelle | Belgium | DELETION OF AMYLOID PRECURSOR PROTEIN EXACERBATES THE PHOSPHORYLATION AND AGGREGATION OF TAU IN MICE EXPRESSING HUMAN MUTANT TAU |
| Levites | Yona | USA | COMBINATION OF PRO-INFLAMMATORY INTERLEUKIN 6 AND ANTI-INFLAMMATORY INTERLEUKIN 10 WITH ANTI-AMILOID BETA IMMUNOTHERAPY AFFECTS AMYLOID DEPOSITION IN AD MOUSE MODEL |
| Levy | Efrat | USA | A MECHANISM FOR ENHANCED EXOSOME SECRETION IN THE BRAIN OF DOWN SYNDROME PATIENTS THAT ALLEVIATES NEURONAL ENDOSOMAL ABNORMALITIES |
| Lichtenthaler | Stefan | Germany | THE BETA-SECRETASE BACE1 CONTROLS SYNAPTIC STRENGTH IN THE MURINE BRAIN |
| Liebsch | Filip | Canada | C-TERMINALLY TRUNCATED ABETA-SPECIES IN THE CSF OF PATIENTS WITH MILD COGNITIVE IMPAIRMENT AND PRE-SYMPTOMATIC ALZHEIMER DISEASE |
| Lin | Chin-Hsien | Taiwan | LOVASTATIN PROTECTS NEURITE DEGENERATION IN LRRK2-G2019S PARKINSONISM THROUGH ACTIVATING THE AKT/NRF PATHWAY AND INHIBITING GSK3ΒETA ACTIVITY |
| Lipsmeier | Florian | Switzerland | REMOTE, HIGH-FREQUENCY MONITORING OF MOTOR SYMPTOMS IN EARLY-STAGE PARKINSON’S DISEASE PATIENTS IN THE PHASE I RG7935/PRX002 CLINICAL TRIAL |
| Lipton | Stuart | USA | REDOX-MEDIATED LINK BETWEEN ALZHEIMER’S DISEASE AND TYPE 2 DIABETES WITH THERAPEUTIC IMPLICATIONS |
| Lleo | Alberto | Spain | CEREBRAL AMYLOID ANGIOPATHY IN DOWN SYNDROME, AUTOSOMAL DOMINANT AND SPORADIC ALZHEIMER´S DISEASE |
| Lobbestael | Evy | Belgium | PHARMACOLOGICAL LRRK2 KINASE INHIBITION INDUCES LRRK2 PROTEIN DESTABILIZATION AND PROTEASOMAL DEGRADATION |
| Logsdon | Benjamin | USA | TRANSCRIPTOMIC NETWORK PRIORITIZATION OF ALZHEIMER’S DISEASE DRIVERS |
| Lombardo | Ilise | USA | PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF INTEPIRDINE (RVT-101) IN DEMENTIA WITH LEWY BODIES: THE HEADWAY-DLB STUDY |
| Longo | Frank | USA | AN ORALLY BIOAVAILABLE SMALL MOLECULE P75 RECEPTOR LIGAND INHIBITS TAU MOLECULAR PATHOLOGY |
| Longoni | Martina | Italy | VALIDATION OF CSF ANTI-AΒ AUTOANTIBODIES AND TISSUE FACTOR PATHWAY INHIBITOR AS DIAGNOSTIC AND PROGNOSTIC BIOMARKERS OF CEREBRAL AMYLOID ANGIOPATHY-RELATED INFLAMMATION |
| Low | Walter | USA | TOWARDS THE GENERATION OF NIGRAL DOPAMINE NEURONS IN GENE EDITED ANIMALS VIA STEM CELL COMPLEMENTATION FOR TREATING PARKINSON DISEASE |
| Lukiw | Walter J. | USA | MICRORNA (MIRNA) SIGNALING IN ALZHEIMER'S DISEASE (AD) |
| Lundgren | Jolanta L. | Sweden | SYNAPTIC LOCALIZATION OF ADAM10 AND BACE1 IN ADULT RAT AND HUMAN BRAIN |
| Maccecchini | Maria | USA | TREATING ACUTE AND CHRONIC NEURODEGENERATION BY INHIBITING NEUROTOXIC AGGREGATING PROTEINS |
| Majid | Oneeb | United Kingdom | E2609, A NOVEL BACE INHIBITOR DEMONSTRATES PROOF-OF-PHARMACOLOGY IN CSF AND PLASMA IN MCI DUE TO AD AND MILD-MODERATE AD DEMENTIA |
| Mandelkow | Eckhard | Germany | TAU FOLDING, MISFOLDING, AND PROPAGATION |
| Mandelkow | Eva-Maria | Germany | ANIMAL MODELS OF TAU PATHOLOGY - TOXICITY WITH OR WITHOUT AGGREGATION |
| Manfredsson | Fredric | USA | NIGROSTRIATAL OVEREXPRESSION OF ALPHA-SYNUCLEIN INDUCES NEURODEGENERATION VIA A TOXIC LOSS OF FUNCTION MECHANISM |
| Marcello | Elena | Italy | CYCLASE-ASSOCIATED PROTEIN 2 (CAP2) CROSSING ALZHEIMER DISEASE PATHOGENESIS PATHWAYS: AMYLOID GENERATION AND ACTIN-DEPENDENT DENDRITIC SPINES SHAPING |
| Marchetti | Bianca | Italy | ADULT STEM/NEUROPROGENITORS TRANSPLANTED IN PARKINSONIAN MOUSE SUBTANTIA NIGRA TRIGGER AN ASTROCYTE-DEPENDENT DOPAMINERGIC NEURORESTORATION: A CHIEF ROLE FOR WNT/BETA-CATENIN SIGNALING NETWORK |
| Marek | Ken | USA | STRATEGIES TO IDENTIFY PARKINSON DISEASE PROGRESSION SUBSETS - THE PPMI STUDY |
| Marizzoni | Moira | Italy | EFFECT OF APOE GENOTYPE ON PATHOLOGICAL CEREBROSPINAL FLUID CUT-POINTS IN MILD COGNITIVE IMPAIRMENT |
| Maroof | Nazia | Switzerland | SEVERITY OF INFLAMMATION MODULATES EXTENT OF ALPHA-SYNUCLEIN ACCUMULATION IN THE ENTERIC NERVOUS SYSTEM |
| Marques | Tainá | The Netherlands | MICRORNAS IN CEREBROSPINAL FLUID AS POTENTIAL BIOMARKERS FOR PARKINSON’S DISEASE AND MULTIPLE SYSTEM ATROPHY |
| Marsh | Samuel | USA | AMYLOID AND TAU PATHOLOGY INDUCE SIGNIFICANT T CELL INFILTRATION IN MOUSE MODELS OF ALZHEIMER’S DISEASE |
| Martinez | Ana | Spain | REGULATION OF TDP-43 PATHOLOGY BY CDC-7 INHIBITORS TREATMENT |
| Maruff | Paul | Australia | SENSITIVITY OF THE ALZHEIMER DISEASE COOPERATIVE STUDY PRECLINICAL ALZHEIMER COGNITIVE COMPOSITE (ADCS-PACC),TO AMYLOID LOAD IN PRECLINICAL AD |
| Masters | Colin | Australia | TARGETING THE DYNAMICS OF ABETA AMYLOID PRODUCTION/CLEARANCE IN SPORADIC ALZHEIMER’S DISEASE |
| Matrone | Carmela | Denmark | ABNORMAL HYPERPHOSPHORYLATION OF TYROSINE RESIDUES ALTERS APP ENDOCYTOSIS IN NEURONS FROM ALZHEMER'S DISEASE AFFECTED PATIENTS. |
| Matsumoto | Yoh | Japan | DEVELOPMENT OF THIRD-GENERATION DNA VACCINES TARGETING A WIDE RANGE OF AMYLOID-BETA AND TAU PEPTIDES IN ALZHEIMER’S DISEASE |
| Mattsson | Niklas | Sweden | TAU PATHOLOGY MEASURED BY 18F-AV1451 PET AND CSF BIOMARKERS IN ALZHEIMER'S DISEASE |
| Mayeux | Richard | USA | WHOLE EXOME AND WHOLE GENOME SEQUENCING IN CARIBBEAN HISPANICS FAMILIES |
| McAleese | Kirsty | United Kingdom | WHITE MATTER LESIONS IN ALZHEIMER'S DISEASE HAVE SIGNIFICANTLY MORE AXONAL LOSS COMPARED TO WHITE MATTER LESIONS IN AGEING |
| McLaurin | JoAnne | Canada | VASCULAR AND NEURONAL COMPROMISE IN TGF344 AD RAT MODEL OF ALZHEIMER’S DISEASE |
| McMillan | Corey | USA | CONVERGING EVIDENCE FOR GENETIC RISK FACTORS OF ALPHA-SYNUCLEIN PATHOLOGY IN ALZHEIMER’S DISEASE |
| Mendonca | Nuno | Germany | COMPARISON OF BIOMARKERS BETWEEN A PHASE 0 STUDY IN ALZHEIMER'S DISEASE AND THE ALZHEIMER’S DISEASE NEUROIMAGING INITIATIVE LONGITUDINAL COHORT |
| Mezias | Christopher | USA | AD-LIKE SPATIOTEMPORAL TAU PATHOLOGY SPREAD, IN MOUSE MODELS, EXHIBITS A RETROGRADE BIAS AND IMPLIES DISEASE INITIATION LOCATION IS RANDOM |
| Michaelson | Daniel M. | Israel | THE ROLE OF HYPOLIPIDATION IN MEDIATING THE PATHOLOGICAL EFFECTS OF APOE4 |
| Mielke | Michelle | USA | PLASMA CERAMIDE TO GLUCOSYLCERAMIDE RATIO IS ASSOCIATED WITH PARKINSON’S DISEASE (PD) SEVERITY AND PREDICTS COGNITIVE DECLINE AMONG COGNITIVELY NORMAL PD PATIENTS WITHOUT GBA MUTATIONS |
| Moechars | Diederik | Belgium | TRANSSYNAPTIC SPREADING OF TAU PATHOLOGY IS MODULATED BY BIN1, A GENETIC RISK FACTOR FOR LATE ONSET ALZHEIMER`S DISEASE |
| Moir | Robert | USA | ROLE OF OLIGOMERS AND HOST CYTOTOXICITY IN THE ANTIMICROBIAL PEPTIDE ACTIONS OF ABETA |
| Mook-Jung | Inhee | Republic of Korea | THE ROLE OF MITOCHONDRIA IN ALZHEIMER'S DISEASE PATHOGENESIS |
| Morales | Rodrigo | USA | PERIPHERAL AMYLOID-BETA SEEDS AS EFFICIENT INDUCERS OF BRAIN AMYLOIDOSIS AND CEREBRAL AMYLOID ANGIOPATHY |
| Morgan | David | USA | DRAMATIC METABOLIC CHANGES IN A MOUSE MODEL OF TAU DEPOSITION AND THE IMPACT OF METABOLIC THERAPY |
| Morizane | Asuka | Japan | CELL THERAPY FOR PARKINSON’S DISEASE WITH INDUCED PLURIPOTENT STEM CELLS |
| Mufson | Elliott | USA | ALZHEIMER'S DISEASE PATHOLOGY IN NON-COGNITIVELY IMPAIRED ELDERS : A ROLE FOR COGNITIVE RESERVE |
| Müller | Ulrike | Germany | ASSESSING THE THERAPEUTIC POTENTIAL OF SAPPALPHA: RESCUE OF SYNAPTIC DYSFUNCTION IN ALZHEIMER MODEL MICE AND CONDITIONAL APP/APLP2 DOUBLE KNOCKOUT MICE |
| Multhaup | Gerhard | Canada | APLP1 IS CLEAVED BY Γ-SECRETASE WITHOUT PREVIOUS ECTODOMAIN SHEDDING |
| Munter | Lisa | Canada | ALTERNATIVE PROCESSING OF APP BY A RHOMBOID PROTEASE |
| Muresan | Virgil | USA | A NEURONAL CULTURE MODEL FOR SPORADIC ALZHEIMER’S DISEASE WITH AMYLOID-Β (AΒ) AND TAU PATHOLOGY, IN THE ABSENCE OF FAD MUTATIONS |
| Murray | Melissa | USA | UTILIZATION OF QUANTITATIVE DIGITAL PATHOLOGY AND RNA-SEQUENCING TO UNCOVER MOLECULAR UNDERPINNINGS OF SELECTIVE HIPPOCAMPAL VULNERABILITY IN ALZHEIMER’S DISEASE VARIANTS |
| Nestor | Peter J. | Germany | THE LANDSCAPE OF BRAIN IRON DYSREGULATION IN EARLY PARKINSON’S DISEASE |
| Neumann | Manuela | Germany | C9ORF72 EXPRESSION IN HEALTH AND DISEASE |
| Neumann | Ulf | Switzerland | EFFECT OF BACE INHIBITION ON NEUROINFLAMMATION, NEURODEGENERATION AND NEURONAL NETWORK ALTERATIONS IN APP-TRANSGENIC MOUSE MODELS |
| Nickels | Sarah | Luxembourg | SYSTEMIC ANALYSIS OF GENOME-WIDE REGULATIONS IN HUMAN NEUROEPITHELIAL STEM CELLS CARRYING LRRK2-G2019S |
| Nicolas | Gaël | France | THE UNSUSPECTED ROLE AND FREQUENCY OF DE NOVO MUTATIONS IN SPORADIC EARLY ONSET ALZHEIMER DISEASE |
| Nilson | Ashley | USA | THE MECHANISM OF BRAIN-DERIVED TAU OLIGOMER INTERNALIZATION IN PRIMARY NEURONS |
| Nilsson | Per | Sweden | SOMATOSTATIN RECEPTOR 1 AGONIST TREATMENT LOWERS AMYLOID BETA PATHOLOGY IN APP-KNOCK-IN MOUSE MODEL |
| Nixon | Ralph | USA | IN VIVO AUTOPHAGY REPORTER DETECTS AUTOLYSOSOME DYSFUNCTION IN NEURONS WELL BEFORE EXTRACELLULAR AMYLOID DEPOSITION IN ALZHEIMER’S DISEASE (AD) MOUSE MODELS |
| Noble | Elizabeth | United Kingdom | CHARACTERISING OLIGOMERIC AMYLOID-BETA IN MOUSE MODELS OF ALZHEIMER’S DISEASE |
| Norambuena | Andres | USA | NADH FLUORESCENT LIFE TIME MICROSCOPY IN LIVE NEURONS UNVEILS A NOVEL LYSOSOME TO MITOCHONDRIA SIGNALING PATHWAY DISRUPTED IN ALZHEIMER'S DISEASE |
| Nordberg | Agneta | Sweden | REGIONAL TAU DEPOSITION IN THE EVOLUTION OF ALZHEIMER´S DISEASE IN RELATION TO AMYLOID AND INFLAMMATION AS STUDIED BY MULTI-TRACER PET |
| Nuber | Silke | USA | SHIFTING MULTIMERS: NEW MOUSE AND CULTURE MODELS OF ALPHA-SYNUCLEIN TRUNCATION BY CALPAIN IN PARKINSON'S DISEASE |
| Oddo | Salvatore | USA | MECHANISMS OF NEURONAL LOSS IN ALZHEIMER’S DISEASE |
| Oeckl | Patrick | Germany | ALPHA-, BETA- AND GAMMA-SYNUCLEIN QUANTIFICATION IN CSF BY HIGHLY SELECTIVE MASS-SPECTROMETRY REVEALS INCREASED CONCENTRATIONS IN ALZHEIMER´S AND CREUTZFELDT-JAKOB DISEASE BUT NO ALTERATION IN SYNUCLEINOPATHIES |
| Offen | Daniel | Israel | A NOVEL CASPASE-6 INHIBITOR AS A POTENTIAL THERAPY FOR ALZHEIMER'S DISEASE |
| Olah | Marta | USA | MICROGLIA IDENTITY IN THE AGED HUMAN BRAIN |
| Olofsson | Anders | Sweden | THE DETERMINANTS CONTROLLING AMYLOID BETA FIBRIL FORMATION |
| Orr | Miranda | USA | ALZHEIMER’S DISEASE ASSOCIATED TAU PATHOLOGY INDUCES CELLULAR SENESCENCE IN BRAIN |
| Ostenfeld | Thor | United Kingdom | SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF MEDI1814, A BETA-AMYLOID 42-SPECIFIC ANTIBODY, IN MILD-MODERATE ALZHEIMER'S DISEASE |
| Otero | Karel | USA | TREM2 IS A CORECEPTOR OF THE MACROPHAGE/MICROGLIA GROWTH FACTOR RECEPTOR CSF-1R |
| Paillusson | Sébastien | United Kingdom | ALPHA-SYNUCLEIN BINDS TO THE ER-MITOCHONDRIA TETHERING PROTEIN VAPB TO DISRUPT CA2+ HOMEOSTASIS AND MITOCHONDRIAL ATP PRODUCTION |
| Palmqvist | Sebastian | Sweden | THE STARTING REGIONS OF AMYLOID-Β ACCUMULATION IN ALZHEIMER’S DISEASE |
| Paquet | Dominik | Germany | A CRISPR/CAS9-BASED GENE EDITING FRAMEWORK ALLOWS MODELING EARLY-ONSET ALZHEIMER’S DISEASE IN GENETICALLY DEFINED HUMAN IPSC LINES |
| Parkkinen | Laura | United Kingdom | ALPHA-SYNUCLEIN RT-QUIC IN THE CSF OF PATIENTS WITH ALPHA-SYNUCLEINOPATHIES - A NEW POTENTIAL DIAGNOSTIC MARKER |
| Pasternak | Stephen | Canada | TREATING DEMENTIA WITH COUGH MEDICINE: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL REPUPOSING AMBROXOL AS A NOVEL DISEASE MODIFYING TREATMENT FOR PARKINSON’S DISEASE DEMENTIA |
| Patra | Kalicharan | Sweden | PLASMA LEVELS OF KALLIKREIN-LIKE PROTEASE 6 ARE INCREASED IN PATIENTS WITH ALZHEIMER’S DISEASE AND APPEAR TO BE ASSOCIATED WITH APOEΕ4 STATUS |
| Paul | Bindu | USA | INTERSECTION OF AMINO ACID METABOLISM AND REDOX HOMEOSTASIS IN HUNTINGTON’S DISEASE |
| Pauls | Eduardo | Spain | NEW CELLULAR MODELS TO STUDY ALZHEIMER'S DISEASE USING CRISPR/CAS9 TECHNOLOGY |
| Pericak-Vance | Margaret | USA | FAMILY-BASED ANALYSES OF WHOLE GENOME SEQUENCING IN WHITE, NON-HISPANIC POPULATIONS |
| Peters | Oliver | Germany | INTERRELATIONSHIP OF BETA AMYLOID RATIO 42/40 AND TTAU AND ITS DEPENDENCY ON APOE GENOTYPE |
| Piazza | Fabrizio | Italy | THE ARIA PARADOX: OFF-KEY OR KEYNOTE IN THE OPERA OF IMMUNOTHERAPY? |
| Pini | Lorenzo | Italy | NON-INVASIVE INTERVENTION IN ALZHEIMER’S DISEASE WITH TRANSCRANIAL DIRECT CURRENT STIMULATION |
| Planel | Emmanuel | Canada | SPINAL CHORD INJURY INDUCES TAU PATHOLOGY IN THE BRAIN |
| Poewe | Werner | Austria | CURRENT DEVELOPMENTS IN THE TREATMENT OF PARKINSON’S DISEASE - FROM DISEASE MODIFICATION TO PREVENTION? |
| Polymenidou | Magdalini | Switzerland | DYNAMIC POLYMERIZATION OF TDP-43 IN HEALTH AND DISEASE |
| Popp | Julius | Switzerland | MACROPHAGE MIGRATION INHIBITORY FACTOR IS ASSOCIATED WITH BIOMARKERS OF ALZHEIMER’S DISEASE PATHOLOGY AND PREDICTS COGNITIVE DECLINE IN MCI AND MILD DEMENTIA. |
| Poston | Kathleen | USA | DOUBLE DISSOCIATION BETWEEN DEFAULT MODE NETWORK CONNECTIVITY AND ABNORMAL CSF BETA-AMYLOID AND PHOSPHORYLATED TAU IN PARKINSON’S DISEASE |
| Prado | Marco | Canada | CHOLINERGIC REGULATION OF RNA METABOLISM, COGNITION AND ALZHEIMER’S PATHOLOGY |
| Prasad | Vibha | Germany | ASSESSMENT OF ALPHA-SYNUCLEIN AGGREGATION AND TRANSMISSION IN VIVO |
| Prashant | Bharadwaj | Australia | THE BETA AMYLOID-AMYLIN INTERACTION: IS THERE A MOLECULAR LINK BETWEEN DIABETES AND ALZHEIMER’S DISEASE? |
| Pratico | Domenico | USA | A NOVEL ROLE FOR CASPASE-3 AS MODULATOR OF TAU PHOSPHORYLATION: IMPLICATIONS FOR ALZHEIMER’S DISEASE AND RELATED TAUOPATHIES |
| Prokopenko | Inga | United Kingdom | ASSOCIATION OF DEMENTIA WITH LEWY BODIES WITH APOE-Ɛ4/TOMM40 LONG POLY-T REPEAT IS DUE TO CO-EXISTING ALZHEIMER’S DISEASE PATHOLOGY |
| Raha-Chowdhury | Ruma | United Kingdom | NEUROPROTECTIVE EFFECT OF TREM-2 IN ALZHEIMER’S DISEASE AND DOWN’S SYNDROME |
| Rahimipour | Shai | Israel | TARGETING THE TOXIC OLIGOMERS OF AMYLOIDOGENIC PROTEINS BY SELF-ASSEMBLED CYCLIC D,L-ALPHA-PEPTIDES: POTENTIAL APPLICATION FOR ALZHEIMER’S AND PARKINSON’S DISEASES |
| Rajendran | Lawrence | Swaziland | DESIGNING SAFER BETA-SECRETASE INHIBITORS FOR ALZHEIMER’S DISEASE THERAPY |
| Rakez | Kayed | USA | TARGETING DISEASE-SPECIFIC TAU OLIGOMERS BY IMMUNOTHERAPY |
| Ranum | Laura | USA | REPEAT ASSOCIATED NON-ATG (RAN) TRANSLATION IN NEUROLOGIC DISEASE: LESSONS FROM C9ORF72 ALS/FTD BAC MICE |
| Reed | Xylena | USA | BAG3 IS A CANDIDATE GENE FOR INCREASED RISK OF SPORADIC PARKINSON’S DISEASE |
| Rektorova | Irena | Czech Republic | FUNCTIONAL CONNECTIVITY PATTERNS IN AD AND PD: LESSONS FROM LONGITUDINAL STUDIES |
| Remnestål | Julia | Sweden | PROTEIN PROFILING IN CSF AND PLASMA REVEALS ASSOCIATIONS OF SYNAPTIC PROTEINS NEUROMODULIN AND NEUROGRANIN TO ALZHEIMER’S DISEASE |
| Riek | Roland | Switzerland | STRUCTURE-ACTIVITY RELATIONSHIPS OF AB(1-42) AMYLOID AND A-SYNUCLEIN MULTIMERS IN AD AND PD |
| Ries | Miriam | United Kingdom | THE ANTI-INFLAMMATORY ANNEXIN A1 AMELIORATES BLOOD BRAIN BARRIER DISRUPTION IN A MOUSE MODEL OF ALZHEIMER’S DISEASE |
| Risacher | Shannon | USA | DIFFERENTIAL ATROPHY PATTERNS IN PARKINSON’S DISEASE WITH COGNITIVE IMPAIRMENT AND ALZHEIMER’S DISEASE WITH PARKINSONIAN SYMPTOMS |
| Robakis | Nikos | USA | FAD MUTANTS INCREASE NEURODEGENERATION BY FORMING TOXICITY-SENSITIVE PROTEIN COMPLEXES AND BLOCKING NEUROTROPHIN-DEPENDENT NEUROPROTECTION |
| Roberts | Jill | USA | EARLY CHANGES IN THE EXTRACELLULAR MATRIX AND BLOOD-BRAIN BARRIER INTEGRITY FOLLOWING MOUSE BILATERAL CAROTID ARTERY STENOSIS |
| Rongve | Arvid | Norway | GENOME WIDE ASSOCIATION STUDY IN LEWY BODY DEMENTIA |
| Rosenzweig | Neta | Israel | THERAPUTIC EFFECT OF PD-1 IMMUNE CHECKPOINT BLOCKADE IN TAU AND AMYLOID-BETA MOUSE MODELS OF ALZHEIMER’S DISEASE |
| Rossor | Martin N. | United Kingdom | WHAT CAN WE LEARN FROM THE TREATMENT OF SYSTEMIC AMYLOIDOSES? |
| Roussotte | Florence | USA | IN VIVO PLAQUE AND TANGLE BURDEN MEDIATES THE ASSOCIATION BETWEEN DIASTOLIC BLOOD PRESSURE AND COGNITIVE PERFORMANCE IN NON-DEMENTED OLDER ADULTS |
| Rovelet-Lecrux | Anne | France | WHOLE EXOME SEQUENCING IN 522 EARLY-ONSET ALZHEIMER PATIENTS REVEALS MAPT DUPLICATIONS AS A CAUSE OF PROMINENT TAU-RELATED DEMENTIA WITH INCREASED MAPT EXPRESSION |
| Ryazantseva | Maria | Russia | ATTENUATED PRESENILIN-1 ENDOPROTEOLYSIS LEADS TO STIM1 GAIN-OF-FUNCTION AND ENHANCED ACTIVATION OF ORAI AND TRPC CHANNELS |
| Saez-Valero | Javier | Spain | SOLUBLE COMPLEXES OF PRESENILIN-1 IN ALZHEIMER’S CEREBROSPINAL FLUID AS AN ASYMPTOMATIC BIOMARKER |
| Saido | Takaomi | Japan | IDENTIFICATION AND CHARACTERIZATION OF ABETA PATHOLOGY-DEPENDENT TAU-BINDING PROTEINS |
| Salta | Evgenia | Belgium | MIR-132: USING NEUROGENESIS TO FIGHT NEURODEGENERATION IN ALZHEIMER’S DISEASE |
| Samieri | Cécilia | France | NUTRIENT BIOMARKER PATTERNS AND RISK OF DEMENTIA |
| Sanabria Diaz | Gretel | Switzerland | APOE*E4 IMPACT ON THE CORTICAL THICKNESS BRAIN NETWORKS TOPOLOGY IN MILD COGNITIVE IMPAIRMENT |
| Sandberg | Anders | Sweden | THIRD GENERATION IMMUNOTHERAPY FOR THE PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE |
| Sannerud | Ragna | Belgium | RESTRICTED LOCATION OF PSEN2/Γ-SECRETASE DETERMINES SUBSTRATE SPECIFICITY AND GENERATES AN INTRACELLULAR AΒ POOL |
| Sardi | Pablo | USA | TARGETING LYSOSOMAL GLUCOCEREBROSIDASE DEFECTS IN THE TREATMENT OF PARKINSON’S DISEASE: FROM GENETICS TO THERAPEUTICS |
| Sargeant | Tim | Australia | MTOR REGULATES TRAFFICKING OF AMYLOID PRECURSOR PROTEIN TO THE LYSOSOME |
| Savonenko | Alena | USA | CLEARANCE OF NEURONAL AND ASTROCYTIC ABETA AND CEREBRAL AMYLOID ANGIOPATHY |
| Schapira | Anthony | United Kingdom | GBA CHAPERONES IN CELL AND ANIMAL MODELS OF GBA-PD; PROSPECTS FOR TREATMENT |
| Schellenberg | Gerard | USA | LARGE-SCALE DNA SEQUENCE ANALYSIS AND ALZHEIMER’S DISEASE GENETICS |
| Scheltens | Philip | The Netherlands | CAN’T SEE THE WOOD FOR THE TREES? A QUICK GUIDE THROUGH ALL THE NEW CRITERIA FOR AD |
| Schemmert | Sarah | Germany | THERAPEUTIC TREATMENT WITH A D-ENANTIOMERIC PEPTIDE IMPROVES COGNITIVE IMPAIRMENT IN AGED APPSWE/PS1 TRANSGENIC MICE |
| Schmidt | Reinhold | Austria | IMAGING OF CEREBRAL SMALL VESSEL DISEASE |
| Schmitt | Karen | Switzerland | DISRUPTED BIOLOGICAL CLOCK LINKED TO AMYLOID-Β-INDUCED IMBALANCE IN MITOCHONDRIAL NETWORK. |
| Schmitz | Taylor | United Kingdom | BASAL FOREBRAIN DEGENERATION PRECEDES AND PREDICTS THE CORTICAL SPREAD OF ALZHEIMER'S PATHOLOGY |
| Schöll | Michael | Sweden | EARLY- AND LATE-ONSET ALZHEIMER’S DISEASE SHOW DISTINCT TAU PATHOLOGY AS EXAMINED WITH 18F-AV-1451 TAU POSITRON EMISSION TOMOGRAPHY |
| Schwartz | Michal | Israel | HARNESSING SYSTEMIC IMMUNITY TO FIGHT NEURODEGENERATIVE DISEASES: THE POTENTIAL OF IMMUNE CHECKPOINT BLOCKADE FOR FIGHTING AGAINST ALZHEIMER'S DISEASE |
| Segal | Menachem | Israel | CALCIUM STORES IN ANIMAL MODELS OF AD |
| Sehlin | Dag | Sweden | EFFICIENT CLEARANCE OF ABETA PROTOFIBRILS IN APP-TRANSGENIC MICE TREATED WITH A BRAIN PENETRATING BIFUNCTIONAL ANTIBODY |
| Selkoe | Dennis | USA | ALPHA-SYNCULEIN MULTIMER-MONOMER EQUILIBRIA AND THE INITIATION OF PARKINSON'S DISEASE |
| Selnes | Per | Norway | SYNAPTIC FUNCTION AND INTEGRITY IS LINKED TO COGNITION IN PARKINSON'S DISEASE |
| Shams | Sara | Sweden | MICROINFARCTS DETECTED ON MRI – ANOTHER IMPORTANT IMAGING BIOMARKER IN COGNITIVE IMPAIRMENT? |
| Sharon | Ronit | Israel | ALPHA -SYNUCLEIN LEVELS IN HUMAN BLOOD CELLS, CSF AND SALIVA DETERMINED BY A LIPID-ELISA: A BIOMARKER FOR PARKINSON’S DISEASE |
| Shen | Jie | USA | PRESENILIN IN HEALTH AND ALZHEIMER’S DISEASE |
| Sher | Emanuele | United Kingdom | HYPER-PHOSPHORYLATED, AGGREGATED AND SEEDING COMPETENT TAU IN RODENT AND HUMAN SYNAPTOSOMES |
| Shiihashi | Gen | Japan | NOVEL ALS/FTD MODEL MICE EXPRESSED CYTOPLASMIC FUS IN A TOXIC GAIN-OF-FUNCTION MANNER |
| Shimizu | Soichiro | Japan | CORRELATION BETWEEN CLINICAL SYMPTOMS AND STRIATAL DAT UPTAKE IN PATIENTS WITH DLB. |
| Shoai | Maryam | United Kingdom | IDENTIFICATION OF AMYLOID POSITIVE INDIVIDUALS IN MCI OR ELDERLY PRE-SYMPTOMATIC COHORTS USING A NOVEL PANEL |
| Shulman | Joshua | USA | EXCESSIVE BURDEN OF LYSOSOMAL STORAGE DISORDER GENE VARIANTS IN PARKINSON’S DISEASE |
| Shutinoski | Bojan | Canada | LEUCINE-RICH REPEAT KINASE-2 (LRRK2) ALLELES REGULATE INFLAMMATION IN VIRULENT INFECTION MODELS |
| Silva | Joana | Portugal | THE “STRESSED” AUTOPHAGY: CHRONIC STRESS EXACERBATES TAU PATHOLOGY BY BLOCKING AUTOPHAGY CLEARANCE SYSTEM |
| Simonovitch | Shira | Israel | APOE4 IMPAIRS AUTOPHAGY IN NEURONS |
| Sisodia | Sangram S. | USA | THE ROLE OF THE MICROBIOME IN MODULATION OF AMYLOID DEPOSITION |
| Small | David H. | Australia | THE ROLE OF APP IN ALZHEIMER’S DISEASE NEXOPATHY: AN ALTERNATIVE TO THE PRION HYPOTHESIS |
| Smrzka | Oskar | Austria | IN VITRO AND IN VIVO FUNCTIONAL EVALUATION OF ANTIBODY-BASED HUNTINGTIN TARGETING STRATEGIES. |
| Snaedal | Jon | Iceland | RETINAL OXYGEN METABOLISM IN ALZHEIMER´S DISEASE |
| Snyder | Peter | USA | DISRUPTION OF CHOLINERGIC NEUROTRANSMISSION IN PRECLINICAL ALZHEIMER’S DISEASE: NOVEL BIOMARKERS FOR EARLY DETECTION |
| Soininen | Hilkka | Finland | THE LIPIDIDIET TRIAL - EFFECTS OF FORTASYN CONNECT IN PRODROMAL ALZHEIMER'S DISEASE |
| Solomon | Beka | Israel | CHRONIC ADMINISTRATION OF AMD 3100 AS A MULTIFACETED THERAPEUTIC STRATEGY FOR TREATMENT OF NEURODEGENERATION |
| Soreq | Hermona | Israel | INTER-RELATED RNA AND LIPID PROCESSING CHANGES IN COGNITIVELY DECLINED ALZHEIMER’S BRAINS |
| Sotiropoulos | Ioannis | Portugal | TAU PROTEIN IS ESSENTIAL FOR STRESS-DRIVEN DEPRESSIVE PATHOLOGY AND COGNITIVE DEFICITS |
| Soto | Claudio | USA | CYCLIC AMPLIFICATION OF PROTEIN MISFOLDING FOR SENSITIVE DIAGNOSIS OF ALZHEIMER'S AND PARKINSON'S DISEASES |
| Späni | Claudia | USA | AN ALZHEIMER’S DISEASE MOUSE MODEL LACKING FUNCTIONAL ADAPTIVE IMMUNE CELLS SHOWS REDUCED AMYLOID PATHOLOGY, ALTERED MICROGLIAL RESPONSES AND REDUCED SURVIVAL |
| Sperling | Reisa | USA | EVOLUTION OF PRECLINICAL ALZHEIMER’S DISEASE: IMPLICATIONS FOR PREVENTION TRIALS |
| Spillantini | Maria Grazia | United Kingdom | DOPAMINERGIC DYSFUNCTION AND NEURONAL DEATH IN A NEW A-SYNUCLEIN TRANSGENIC MODEL IS RESCUED BY ANLE138B BY AFFECTING A-SYNUCLEIN AGGREGATES DENSITY |
| St. George-Hyslop | Peter | Canada | EFFECT OF THE AD-RELATED TREM2 R47H MUTATION ON TREM2 FUNCTION |
| Steen | Judith | USA | TAU CHEMISTRY IS DISTINCT FOR ALZHEIMER’S DISEASE AND OTHER TAUOPATHIES |
| Steen | Hanno | USA | GLOBAL ANALYSIS OF TAUOPATHY PATIENTS IDENTIFIES BOTH COMMON AND SPECIFIC DISEASE PATHWAYS |
| Stefanova | Nadia | Austria | TARGETING ALPHA-SYNUCLEIN PATHOLOGY WITH THE MOLECULAR TWEEZER CLR01 IN MULTIPLE SYSTEM ATROPHY |
| Stephens | Andrew | USA | CHARACTERIZATION OF NOVEL PET TRACERS FOR THE ASSESSMENT OF TAU PATHOLOGY IN ALZHEIMER’S DISEASE AND OTHER TAUOPATHIES |
| Stevens | Beth | USA | IMMUNE MECHANISMS OF SYNAPSE LOSS IN AD: LESSONS FROM DEVELOPMENT |
| Streffer | Johannes | Belgium | INTERACTION OF TAU AND AMYLOID PATHOLOGY IS RELEVANT FOR COGNITIVE CHANGES. MOVING THE AMYLOID CASCADE HYPOTHESIS TO AN INTERACTION MODEL? |
| Strosznajder | Joanna | Poland | INTERFERENCE BETWEEN PARP-1 AND SIRTUINS: THE ROLE IN REGULATION OF GENE EXPRESSION AND MITOCHONDRIA FUNCTION IN MODEL OF ALZHEIMER’S DISEASE |
| Stutzmann | Grace | USA | EARLY SYNAPTIC DEFICITS IN AD PATHOGENESIS |
| Südhof | Thomas | USA | APOE, SYNAPSES, AND ALZHEIMER’S DISEASE |
| Suh | Yoo-Hun | Republic of Korea | INVOLVEMENT OF 14-3-3 IN TUBULIN INSTABILITY AND IMPAIRED AXON DEVELOPMENT MEDIATED BY TAU |
| Suh | Jaehong | USA | DEPLETION OF ATAXIN-1 INCREASES BACE1 EXPRESSION AND IMPAIRS AXON GUIDANCE IN CEREBRUM |
| Suter-Dick | Laura | Switzerland | A THREE-DIMENSIONAL, HUMAN CO-CULTURE MODEL FOR THE STUDY OF MECHANISMS IN ALZHEIMER'S DISEASE |
| Syvänen | Stina | Sweden | ANTIBODY-BASED PET RADIOLIGANDS FOR IMAGING OF AMYLOID-BETA PROTOFIBRILS |
| Taga | Mariko | USA | STUDY OF CD33: AN ALZHEIMER’S DISEASE SUSCEPTIBILITY LOCUS IN NEURODEGENERATION |
| Takenoshita | Naoto | Japan | COMPARISON OF DIAGNOSTIC UTILITY OF SEMI-QUANTITATIVE ANALYSIS FOR DAT-SPECT FOR DISTINGUISHING DLB FROM AD |
| Tamgüney | Erdem Gültekin | Germany | ΑLPHA-SYNUCLEIN PRIONOIDS NEUROINVADE THE CNS AFTER PERIPHERAL INJECTION |
| Tanzi | Rudolph | USA | MODELING ALZHEIMER’S DISEASE IN THE WHOLE GENOME ERA |
| Taylor | Graeme | Canada | DISRUPTIONS IN LAND’S CYCLE REMODELLING OF MEMBRANE GLYCEROPHOSPHOCHOLINES ARE A DEFINING ALZHEIMER’S DISEASE PATHOLOGY |
| Tba | | | HETEROMERIZATION OF M1 MUSCARINC/SIGMA1 RECEPTORS AS A UNIQUE AD THERAPEUTIC TARGET |
| Tcw | Julia | USA | AN EFFICIENT PLATFORM FOR ASTROCYTE DIFFERENTIATION FROM HUMAN INDUCED PLURIPOTENT STEM CELLS: APPLICATION TO APOE GENOTYPE SPECIFIC EFFECTS ON GENE EXPRESSION AND FUNCTION |
| Teunissen | Charlotte | The Netherlands | NOVEL CSF BIOMARKERS DISCRIMINATING FTLD-TDP FROM NON-DEMENTED CONTROLS |
| Thal | Dietmar | Belgium | CEREBRAL AMYLOID ANGIOPATHY, MICROINFARCTION AND THE DEVELOPMENT OF DEMENTIA. |
| Thaler | Avner | Israel | GAIT IN HEALTHY CARRIERS AND NON-CARRIERS OF MUTATIONS IN THE GBA GENE: POTENTIAL CLINICAL MARKERS OF DISEASE |
| Thierry | Manon | France | THE ROLE OF AXONS IN THE PROPAGATION OF THE LESIONS IN ALZHEIMER'S DISEASE: A STUDY OF THE PILLAR OF THE FORNIX |
| Toda | Tatsushi | Japan | ASSOCIATION STUDY OF PARKINSON’S DISEASE BY SNP AND EXOME SEQUENCING |
| Tofaris | George | United Kingdom | SEEDED AGGREGATION OF Α-SYNUCLEIN INDUCES A DISTINCT PATTERN OF UBIQUITIN PERTURBATIONS IN HUMAN CELLS |
| Toth | Gergely | Hungary | MONOMERIC ALPHA-SYNUCLEIN INTERACTS THROUGH ITS N-TERMINAL WITH DJ-1 PROTEIN OXIDIZED AT CYS106: IMPLICATIONS FOR OF ALPHA-SYNUCLEIN AGGREGATION INHIBITION BY DJ-1 |
| Tousi | Babak | USA | EFFECTS OF A COMBINED TRANSCRANIAL MAGNETIC STIMULATION (TMS) AND COGNITIVE TRAINING IN ALZHEIMER PATIENTS: SAFETY RESULTS OF MEDICAL DEVICE PIVOTAL MULTI-CENTER STUDY |
| Trabzuni | Daniah | United Kingdom | CHARACTERIZING GENE EXPRESSION AND SPLICE ISOFORMS OF LRRK2 IN HUMAN BRAIN: TOOLS FOR UNDERSTANDING COMPLEX NEURODEGENERATIVE DISEASES |
| Tran Zhao | Hien | USA | ANTISENSE OLIGONUCLEOTIDES TO LRRK2 AMELIORATE ALPHA-SYNUCLEIN PATHOLOGY AND BEHAVIORAL DEFICIT INDUCED BY PRE-FORMED ALPHA-SYNUCLEIN FIBRILS |
| Trojanowski | John Q. | USA | INTERACTIONS OF HUMAN ALZHEIMERS DISEASE (AD) BRAIN DERIVED PATHOLOGICAL TAU (AD-TAU) WITH AΒ DEPOSITS IN AMYLOID PRECURSOR PROTEIN TRANGENIC AND KNOCK IN (KI) MICE |
| Tronel | Claire | France | SIMVASTATIN, BUT NOT ATORVASTATIN, HAS ANTI-INFLAMMATORY AND NEUROPROTECTIVE EFFECTS IN AN IN VIVO RAT MODEL OF HUNTINGTON DISEASE |
| Twohig | Daniel | Sweden | CEREBROSPINAL FLUID LEVELS OF ALPHA-SYNUCLEIN ARE RELATED TO DISEASE PROGRESSION AND APOEΕ4 GENOTYPE IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT |
| Tyagi | Richa | USA | ROLE OF INOSITOL PHOSPHATE SIGNALING PATHWAY IN ALZHEIMER’S DISEASE |
| Udeh-Momoh | Chinedu | United Kingdom | THE CHARIOT COGNITIVE RESERVE COMPOSITE: A CONSTRUCT AND PREDICTIVE VALIDITY STUDY |
| Ugrumov | Michael | Russia | DOPAMINE SYNTHESIS BY STRIATAL NON-DOPAMINERGIC NEURONS: HITHERTO UNKNOWN MECHANISM OF NEUROPLASTICITY AT PARKINSONISM |
| Umansky | Samuil | USA | CIRCULATING BRAIN-ENRICHED MICRORNAS AS BIOMARKERS OF NEURODEGENERATIVE DISEASES |
| Umeda | Tomohiro | Japan | THE OSAKA MUTATION KNOCKIN MICE SHOW RECESSIVE HEREDITARY DEMENTIA VIA GABAERGIC DEPLETION |
| Unschuld | Paul G. | Switzerland | TRACKING PATHOLOGY ASSOCIATED WITH PRECLINICAL BRAIN CHANGE IN SUBJECTS AT RISK FOR AD |
| Van Broeckhoven | Christine | Belgium | PROGRESS IN UNRAVELLING THE GENETICS OF EARLY-ONSET DEMENTIA |
| Van Dam | Anne-Marie | The Netherlands | EARLY MICROGLIAL ACTIVATION BEYOND THE SUBSTANTIA NIGRA IN PARKINSON’S DISEASE |
| Van Der Brug | Marcel | USA | CHARACTERIZATION OF TAU FRAGMENTATION IN ALZHEIMER’S DISEASE CORTEX AND CSF |
| Van der Zee | Julie | Belgium | TBK1 MUTATION SPECTRUM AND FREQUENCY IN AN EUROPEAN STUDY COHORT OF FRONTOTEMPORAL DEMENTIA AND AMYOTROPHIC LATERAL SCLEROSIS PATIENTS |
| Van Kolen | Kristof | Belgium | DEVELOPMENT AND CHARACTERIZATION OF AN IN VIVO TAU SEEDING MODEL TO EVALUATE THE EFFICACY OF ANTI-TAU ANTIBODIES |
| Van Westen | Danielle | Sweden | PERIVASCULAR SPACES IN THE HIPPOCAMPUS ARE ASSOCIATED WITH MARKERS OF VASCULAR DISEASE, AND NOT OF ALZHEIMER'S DISEASE |
| Vance | Jeffery | USA | GENOME-WIDE METHYLATION ANALYSIS OF THE DORSAL MOTOR NUCLEUS OF THE VAGUS DEMONSTRATES EPIGENETIC CHANGES AS A CONTRIBUTION TO THE RISK OF PD |
| Vassar | Robert | USA | BACE1: PROMISE AND CHALLENGES AS A THERAPEUTIC TARGET FOR ALZHEIMER’S DISEASE |
| Viglietta | Vissia | USA | 12-MONTH INTERIM ANALYSIS OF APOE4 CARRIERS FOR FIXED AND TITRATION DOSING REGIMENS IN PRIME, A PHASE 1B STUDY OF ADUCANUMAB |
| Vijaya Kumar | Deepak Kumar | USA | ABETA PEPTIDE AGGLUTINATES AND NEUTRALIZES ENDOTOXINS RELEASED DURING INFECTION |
| Villemagne | Victor | Australia | COMBINATION OF CONTINUOUS AND CATEGORICAL TAU BURDEN MEASURES OBTAINED WITH THREE DIFFERENT TAU TRACERS: 18F-AV1451, 18F-THK5317 AND 18F-THK5351 |
| Virdee | Jasmeet | United Kingdom | EVALUATING FUNCTIONAL READOUTS IN ORGANOTYPIC HIPPOCAMPAL SLICES IN AN EX-VIVO MODEL OF TAU AGGREGATION |
| Vöglein | Jonathan | Germany | SEIZURES IN FAMILIAL ALZHEIMER’S DISEASE |
| Voigt | Aaron | Germany | CAG REPEAT TRANSLATIONAL FIDELITY AS A THERAPEUTIC AVENUE FOR TREATING POLYGLUTAMINE DISEASE |
| Wagner | Matias | Germany | CLINICAL WHOLE EXOME SEQUENCING IN 66 PATIENTS WITH FAMILIAL FRONTOTEMPORAL DEMENTIA |
| Wagner | Lisa | USA | AGE-DEPENDENT, SELECTIVE DOPAMINERGIC NEURODEGENERATION, PROTEIN ACCUMULATION AND AUTOPHAGY IMPAIRMENT IN LRRK-DEFICIENT MICE |
| Walker | Lauren | United Kingdom | INVESTIGATING THE EFFECTS OF MULTIPLE PATHOLOGICAL LESIONS ON MOTOR DYSFUNCTION |
| Walter | Jochen | Germany | PATHOLOGICAL VARIANTS OF AMYLOID Β-PLAQUES AND CEREBRAL AMYLOID ANGIOPATHY IN ALZHEIMER'S DISEASE |
| Wang | Li-San | USA | ROLE AND RESOURCES OF NATIONAL INSTITUTE ON AGING GENETICS OF ALZHEIMER’S DISEASE DATA STORAGE SITE AND GENOME CENTER FOR ALZHEIMER’S DISEASE |
| Waninger | Shani | USA | SUSTAINED ATTENTION AND MEMORY TASKS WITH CONCURRENT EEG PROVIDE POTENTIAL BIOMARKERS FOR MILD COGNITIVE IMPAIRMENT |
| Watterson | Daniel Martin | USA | NEW CANDIDATES FOR CNS STRESS KINASE MODULATION IN CNS DISORDERS |
| Wattmo | Carina | Sweden | THE OUTCOMES OF DIFFERENT ASSESSMENT SCALES CAN PREDICT SURVIVAL IN PATIENTS WITH ALZHEIMER’S DISEASE |
| Wauters | Sandrine | United Kingdom | METHODOLOGY OF CULTURING FIBROBLASTS FROM PATHOLOGICALLY CONFIRMED NEURODEGENERATIVE DISORDERS |
| Weggen | Sascha | Germany | PATHOGENIC ABETA PRODUCTION BY HETEROZYGOUS PRESENILIN-1 (PSEN1) MUTANTS REQUIRES CATALYTIC ACTIVITY AND IS NOT MEDIATED BY CONFORMATIONAL HINDRANCE OF WILD TYPE PSEN1 |
| Wegmann | Susanne | USA | MISFOLDING AND AGE INFLUENCE HUMAN TAU PROPAGATION AND PATHOLOGY IN MICE |
| Weihofen | Andreas | USA | BINDING AND FUNCTIONAL CHARACTERIZATION OF HUMAN-DERIVED ANTI-ALPHA-SYNUCLEIN ANTIBODY BIIB054 |
| Weiner | Michael | USA | VALIDATION OF AMYLOID AND TAU BIOMARKERS FOR AD DIAGNOSIS AND THERAPY-MONITORING: ALZHEIMER’S DISEASE NEUROIMAGING INITIATIVE (ADNI) |
| Weiner | Howard | USA | IMMUNE MECHANISMS IN ALZHEIMER’S DISEASE |
| Westaway | David | Canada | INBRED MODELS OF 4-REPEAT TAUOPATHY WITH SLOW PATHOGENESIS REVEAL FOCAL AND DIVERSE PATTERNS OF TAU ACCUMULATION |
| Westman | Eric | Sweden | SUBTYPES OF ALZHEIMER’S DISEASE BASED ON PATTERNS OF BRAIN ATROPHY: LONGITUDINAL TRAJECTORIES AND CLINICAL APPLICATIONS |
| Wilcock | Donna | USA | THE ROLE OF NEUROVASCULAR ASTROCYTES IN DEMENTIA |
| Wilhelmus | Micha | The Netherlands | BLOOD-DERIVED FACTOR XIIIA FORMS UNIQUE COMPLEXES WITH AΒ IN CEREBRAL AMYLOID ANGIOPATHY |
| Willem | Michael | Germany | ETA-SECRETASE PROCESSING OF APP INHIBITS HIPPOCAMPAL NEURONAL ACTIVITY |
| Willén | Katarina | Sweden | ESCRT DEPENDENT ACCUMULATION OF ALZHEIMER’S AΒ IN ENDOSOMES AND THE EFFECT OF AΒ ON ENDOSOMAL ENLARGEMENT |
| Wolozin | Benjamin | USA | REDUCTION OF THE RNA BINDING PROTEIN TIA1 PROTECTS AGAINST TAUOPATHY INDEPENDENT OF TAU AGGREGATION |
| Wong | Philip | USA | AN ALZHEIMER’S MODEL FOR DETERMINING FACTORS NECESSARY TO DRIVE THE CONVERSION OF TAU |
| Wray | Selina | United Kingdom | INVESTIGATING TAU PATHOLOGY IN ALZHEIMER’S DISEASE AND FRONTOTEMPORAL DEMENTIA USING PATIENT-DERIVED NEURONS |
| Wszolek | Zbigniew | USA | CSF1R-RELATED LEUKOENCEPHALOPATHY |
| Xu | Huaxi | USA | A NEW ROLE FOR THE AD-RISK COMPONENT SORLA IN NEUROPROTECTION FROM AMYLOID TOXICITY |
| Yablonskiy | Dmitriy | USA | IN VIVO DETECTION OF BRAIN PATHOLOGY IN PRECLINICAL AND EARLY ALZHEIMER DISEASE WITH GRADIENT ECHO PLURAL CONTRAST MRI |
| Young-Pearse | Tracy | USA | CELL-TYPE DEPENDENT ALZHEIMER'S DISEASE PHENOTYPES: PROBING THE BIOLOGY OF SELECTIVE NEURONAL VULNERABILITY |
| Yue | Zhenyu | USA | UNCOVERING THE SIGNALING TRANSDUCTION PATHWAYS FOR PARKINSON’S GENE LRRK2 IN CENTRAL NERVOUS SYSTEM |
| Yue | Chunmei | China | HUMAN INDUCED NEURAL PROGENITORS FUNCTION PROPERLY IN ANIMAL MODELS OF ALZHEIMER’S DISEASE |
| Zetterberg | Henrik | Sweden | FLUID BIOMARKERS FOR AD AND PD - RELATION TO PATHOLOGY, IMAGING AND CLINICAL DISEASE PROGRESSION |
| Zhang | Yu | USA | PATTERNS OF BRAIN MICROSTRUCTURAL DEGENERATION DIFFERENTIATE CLINICALLY DIAGNOSED PROGRESSIVE SUPRANUCLEAR PALSY AND CORTICOBASAL DEGENERATION FROM PARKINSON’S DISEASE |
| Zhang | Jianhua | USA | REGULATION OF AUTOPHAGY, MITOCHONDRIAL DYNAMICS AND CELLULAR BIOENERGETICS BY 4-HYDROXYNONENAL IN PRIMARY NEURONS |
| Zhou | Jiawei | China | HSP22/BRG3 MEDIATES THE DIFFERENTIAL DEGENERATION OF MIDBRAIN DOPAMINERGIC NEURONS |
| Zlokovic | Berislav | USA | BLOOD BRAIN BARRIER DYSFUNCTION, NEURODEGENERATION AND ALZHEIMER’S DISEASE |
| Zunke | Friederike | USA | FORMATION OF TOXIC A-SYNUCLEIN ASSEMBLIES BY GLUCOSYLCERAMIDE IN HUMAN MIDBRAIN DOPAMINE NEURONS |
